PW Medtech Group Ltd
HKEX:1358
Intrinsic Value
PW Medtech Group Ltd. is an investment holding company, which engages in the manufacture and sale of infusion set products. [ Read More ]
The intrinsic value of one PW Medtech Group Ltd stock under the Base Case scenario is 1.84 HKD. Compared to the current market price of 0.95 HKD, PW Medtech Group Ltd is Undervalued by 48%.
Valuation Backtest
PW Medtech Group Ltd
Run backtest to discover the historical profit from buying and selling PW Medtech Group Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
PW Medtech Group Ltd
| Current Assets | 1.9B |
| Cash & Short-Term Investments | 1.4B |
| Receivables | 268.9m |
| Other Current Assets | 171.1m |
| Non-Current Assets | 3.2B |
| Long-Term Investments | 371.5m |
| PP&E | 940m |
| Intangibles | 1.7B |
| Other Non-Current Assets | 217.3m |
| Current Liabilities | 152m |
| Accounts Payable | 36m |
| Accrued Liabilities | 34.5m |
| Other Current Liabilities | 81.5m |
| Non-Current Liabilities | 899.4m |
| Long-Term Debt | 762k |
| Other Non-Current Liabilities | 898.6m |
Earnings Waterfall
PW Medtech Group Ltd
|
Revenue
|
675.1m
CNY
|
|
Cost of Revenue
|
-294.2m
CNY
|
|
Gross Profit
|
380.9m
CNY
|
|
Operating Expenses
|
-191.2m
CNY
|
|
Operating Income
|
189.7m
CNY
|
|
Other Expenses
|
-36.5m
CNY
|
|
Net Income
|
153.2m
CNY
|
Free Cash Flow Analysis
PW Medtech Group Ltd
Profitability Score
Profitability Due Diligence
PW Medtech Group Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Score
PW Medtech Group Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
PW Medtech Group Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
PW Medtech Group Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
PW Medtech Group Ltd
According to Wall Street analysts, the average 1-year price target for PW Medtech Group Ltd is 2.35 HKD .
Shareholder Return
Price
PW Medtech Group Ltd
| Average Annual Return | -6.84% |
| Standard Deviation of Annual Returns | 46.86% |
| Max Drawdown | -79% |
| Market Capitalization | 1.5B HKD |
| Shares Outstanding | 1 569 246 100 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
PW Medtech Group Ltd. is an investment holding company, which engages in the manufacture and sale of infusion set products. The company is headquartered in Beijing, Beijing and currently employs 670 full-time employees. The company went IPO on 2013-11-08. The firm operates through three business segments. The Infusion Set Business segment is engaged in the manufacturing and sales of infusion sets. The Orthopedic Implant Business segment is engaged in the manufacturing and sales of orthopedic implant products, including product category of trauma, spine and joints. The Regenerative Medical Biomaterial Business segment is engaged in the manufacturing and sales of regenerative medical biomaterial products.
Contact
IPO
Employees
Officers
The intrinsic value of one PW Medtech Group Ltd stock under the Base Case scenario is 1.84 HKD.
Compared to the current market price of 0.95 HKD, PW Medtech Group Ltd is Undervalued by 48%.
You don't have any saved screeners yet
